You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 12, December 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Choroidal Neovascularization
 •Macular Degeneration
 •Retinal/ Chorioretinal Disorders
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Expression of LOX-1, an Oxidized Low-Density Lipoprotein Receptor, in Choroidal Neovascularization

Arch Ophthalmol. 2004;122:1873-1876.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Subfoveal choroidal neovascularization of various macular diseases is one of the causes of severe blindness, including age-related macular degeneration (AMD). Several environmental risk factors have been elucidated in the pathogenesis of AMD, including smoking,1 atherosclerosis,2 increased levels of plasma fibrinogen,3 and low levels of antioxidant vitamins.4 Recent observations support the hypothesis that antioxidant and/or vitamin treatment may delay progression of AMD and vision loss.5 However, the exact cause of AMD remains to be determined.

Recently, Ikeda et al6 showed that increased plasma oxidized low-density lipoprotein (oxLDL) levels may be involved in the pathogenesis of AMD. Oxidized LDL has been implicated as having a major role in atherosclerosis, and many of the pathologic and biochemical features seen in choroidal neovascularization are analogous to those seen in advanced atherosclerosis, such as the infiltration of monocytes and macrophages and the overexpression of adhesion molecules, monocyte chemotactic proteins, growth factors, and cytokines within lesions.7-8 . . . [Full Text of this Article]


AUTHOR INFORMATION
Megumi Honjo, MD, PhD; Tatsuya Sawamura, MD, PhD; Junichi Hinagata, PhD; Kayo Nakamura, PhD; Nobuhito Sanada, PhD; Hidenobu Tanihara, MD, PhD; Yoshihito Honda, MD, PhD; Junichi Kiryu, MD, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Suppression of Choroidal Neovascularization in Lectin-like Oxidized Low-Density Lipoprotein Receptor Type 1-Deficient Mice
Inomata et al.
IOVS 2009;50:3970-3976.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.